SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes

NCT06148259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-11-28

No results posted yet for this study

Summary

The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus

Conditions

Interventions

OTHER

International prostate symptom score

Questionnaire of 8 questions to be administered to all patients about prostate symptoms

DIAGNOSTIC_TEST

Assessment of prostate volume

Measurements using ultrasound

OTHER

Pittsburgh sleep quality Index

Questionnaire to assess quality of sleep

DIAGNOSTIC_TEST

Glycated hemoglobin

Measures control of diabetes

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Tarek Abdelaziz · Cairo University Kasr Alainy Faculty of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-12
Primary Completion
2022-09-13
Completion
2022-09-13

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148259 on ClinicalTrials.gov